-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 19999 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRc/CMV
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5448
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsDH5 alpha or XL1 @ 37˚C
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namevon Hippel-Lindau tumor suppressor (VHL)
-
Alt namevHL
-
SpeciesH. sapiens (human)
-
Insert Size (bp)745
-
Mutationwild type
-
GenBank IDNM_000551
-
Entrez GeneVHL (a.k.a. HRCA1, RCA1, VHL1, pVHL)
-
Tag
/ Fusion Protein
- HA-tag (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Hind III (destroyed during cloning)
- 3′ cloning site Xba I (destroyed during cloning)
- 5′ sequencing primer T7
- 3′ sequencing primer SP6 (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
HA-VHL-pRc/CMV was a gift from William Kaelin (Addgene plasmid # 19999 ; http://n2t.net/addgene:19999 ; RRID:Addgene_19999) -
For your References section:
Tumour suppression by the human von Hippel-Lindau gene product. Iliopoulos O, Kibel A, Gray S, Kaelin WG. Nat Med. 1995 Aug . 1(8):822-6. 10.1038/nm0895-822 PubMed 7585187